Vital Therapeutics And Formulations Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 8.60 Cr
- Company Age 20 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.50 Cr
- Satisfied Charges ₹ 7.30 Cr
- Revenue Growth -21.45%
- Profit Growth -27.39%
- Ebitda -23.43%
- Net Worth 19.72%
- Total Assets 17.65%
About Vital Therapeutics And Formulations
Vital Therapeutics And Formulations Private Limited (VTAFPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 25 February 2004 and has a history of 20 years and 11 months. Its registered office is in Hyderabad, Telangana.
The Corporate was formerly known as S.M. Pharma & Neutraceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 8.60 Cr.
The company currently has active open charges totaling ₹8.50 Cr. The company has closed loans amounting to ₹7.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Venugopal Sarvisetty and Ramesh Sarvisetty serve as directors at the Company.
Company Details
- Location Hyderabad, Telangana
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239TG2004PTC042735
- Company No.
042735
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Feb 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Vital Therapeutics And Formulations Private Limited offer?
Vital Therapeutics And Formulations Private Limited offers a wide range of products and services, including Company Law & Labour Law Consultants, Statutory Compliance Services, Pharmaceutical Machinery & Equipment, Pharmaceutical Machines, Medical Treatment Services, Therapeutic Service, Vending Machine Part, Coin Validators, Pharmaceutical Services, Pharmaceutical Testing Services.
Who are the key members and board of directors at Vital Therapeutics And Formulations?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Venugopal Sarvisetty ![]() | Managing Director | 25-Feb-2004 | Current |
Board Members (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ramesh Sarvisetty ![]() | Whole-Time Director | 25-Feb-2004 | Current |
Financial Performance of Vital Therapeutics And Formulations.
Vital Therapeutics And Formulations Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 21.45% decrease. The company also saw a substantial fall in profitability, with a 27.39% decrease in profit. The company's net worth Soared by an impressive increase of 19.72%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Vital Therapeutics And Formulations?
In 2023, Vital Therapeutics And Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹8.50 Cr
₹7.30 Cr
Charges Breakdown by Lending Institutions
- Others : 8.50 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
28 Jan 2023 | Others | ₹8.50 Cr | Open |
25 Apr 2018 | Others | ₹4.00 Cr | Satisfied |
28 Jul 2005 | State Bank Of Hyderabad | ₹3.30 Cr | Satisfied |
How Many Employees Work at Vital Therapeutics And Formulations?
Vital Therapeutics And Formulations has a workforce of 12 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Vital Therapeutics And Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vital Therapeutics And Formulations's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.